Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Cancer Vaccines01:30

Cancer Vaccines

363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Longitudinal Association of Quantitative Background Parenchymal Enhancement with Breast Cancer Risk Among Women with BRCA1/2 Pathogenic Variants.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study.

Cancer research communications·2026
Same author

Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification.

Nature communications·2026
Same author

Influence of Tumor-Draining Lymph Nodes on Immunotherapy: Lymphadenectomy May Have Its Limits.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma.

Science (New York, N.Y.)·2026
Same author

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Nature·2026
Same journal

Type II JAK2 Inhibitor Gets Off to a Strong Start.

Cancer discovery·2026
Same journal

Pancreatic Cancer: Translating Tumor Biology into Actionability.

Cancer discovery·2026
Same journal

Reconsidering Cancer Therapy through the Lens of Biomolecular Condensates.

Cancer discovery·2026
Same journal

The Promise of Machine Learning-Based Population Screening for Hepatocellular Carcinoma.

Cancer discovery·2026
Same journal

Spatially Resolved Proteomic Cartography Illuminates the Earliest Molecular Programs in Pancreatic Cancer Evolution.

Cancer discovery·2026
Same journal

Oral Regimens for AML Make Strides.

Cancer discovery·2026
查看所有相关文章

相关实验视频

Updated: Jun 29, 2025

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.3K

推进癌症的拦截 癌症的拦截

Susan M Domchek1,2,3, Robert H Vonderheide2,3

  • 1Basser Center for BRCA1/2, University of Pennsylvania, Philadelphia, Pen-nsylvania.

Cancer discovery
|April 4, 2024
PubMed
概括
此摘要是机器生成的。

癌症拦截,使用先进的技术和遗传检测,旨在消除癌前条件. 新的向疗法和免疫拦截策略需要不同的临床方法,与当前的癌症治疗不同.

更多相关视频

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
07:47

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Published on: December 15, 2023

684
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

749

相关实验视频

Last Updated: Jun 29, 2025

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.3K
Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
07:47

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Published on: December 15, 2023

684
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

749

科学领域:

  • 在瘤学瘤学.
  • 遗传学 遗传学 是一个
  • 治疗方法 治疗方法

背景情况:

  • 技术和治疗方面的进步正在加速癌症研究.
  • 正在出现更好的方法来识别患癌症风险较高的个体.
  • 基因检测为个性化癌症风险评估提供了新的途径.

研究的目的:

  • 介绍癌症拦截的概念和潜力.
  • 突出针对性疗法和免疫拦截的作用.
  • 强调需要新的临床试验和治疗模式.

主要方法:

  • 审查瘤学的最新技术和治疗进展.
  • 基因测试和风险分层方法的分析.
  • "免疫拦截"策略的概念化.

主要成果:

  • 由于技术进步,癌症拦截变得越来越可行.
  • 向治疗和免疫拦截在消除前恶性病变方面表现有前途.
  • 目前的临床试验和治疗框架对于拦截策略是不够的.

结论:

  • 癌症拦截代表了瘤学的范式转变.
  • 新的治疗策略,如向疗法和免疫拦截,是关键.
  • 需要明确的临床方法来实现癌症拦截的潜力.